175 related articles for article (PubMed ID: 1311423)
1. Product of vav proto-oncogene defines a new class of tyrosine protein kinase substrates.
Bustelo XR; Ledbetter JA; Barbacid M
Nature; 1992 Mar; 356(6364):68-71. PubMed ID: 1311423
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine phosphorylation of vav proto-oncogene product containing SH2 domain and transcription factor motifs.
Margolis B; Hu P; Katzav S; Li W; Oliver JM; Ullrich A; Weiss A; Schlessinger J
Nature; 1992 Mar; 356(6364):71-4. PubMed ID: 1531699
[TBL] [Abstract][Full Text] [Related]
3. Insulin-like growth factor-1 induces rapid tyrosine phosphorylation of the vav proto-oncogene product.
Uddin S; Yetter A; Katzav S; Hofmann C; White MF; Platanias LC
Exp Hematol; 1996 Apr; 24(5):622-7. PubMed ID: 8605967
[TBL] [Abstract][Full Text] [Related]
4. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
Kamps MP; Sefton BM
Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
[TBL] [Abstract][Full Text] [Related]
5. Single point mutations in the SH2 domain impair the transforming potential of vav and fail to activate proto-vav.
Katzav S
Oncogene; 1993 Jul; 8(7):1757-63. PubMed ID: 8510922
[TBL] [Abstract][Full Text] [Related]
6. Crk protein binds to PDGF receptor and insulin receptor substrate-1 with different modulating effects on PDGF- and insulin-dependent signaling pathways.
Sorokin A; Reed E; Nnkemere N; Dulin NO; Schlessinger J
Oncogene; 1998 May; 16(19):2425-34. PubMed ID: 9627109
[TBL] [Abstract][Full Text] [Related]
7. Interactions of the SH2 domain of lymphocyte-specific tyrosine protein kinase p56lck with phosphotyrosine-containing proteins.
Peri KG; Gervais FG; Weil R; Davidson D; Gish GD; Veillette A
Oncogene; 1993 Oct; 8(10):2765-72. PubMed ID: 7690927
[TBL] [Abstract][Full Text] [Related]
8. Molecular interactions of the Src homology 2 domain protein Shb with phosphotyrosine residues, tyrosine kinase receptors and Src homology 3 domain proteins.
Karlsson T; Songyang Z; Landgren E; Lavergne C; Di Fiore PP; Anafi M; Pawson T; Cantley LC; Claesson-Welsh L; Welsh M
Oncogene; 1995 Apr; 10(8):1475-83. PubMed ID: 7537362
[TBL] [Abstract][Full Text] [Related]
9. p95vav associates with tyrosine-phosphorylated SLP-76 in antigen-stimulated T cells.
Tuosto L; Michel F; Acuto O
J Exp Med; 1996 Sep; 184(3):1161-6. PubMed ID: 9064333
[TBL] [Abstract][Full Text] [Related]
10. The proto-oncogene Vav product is constitutively tyrosine-phosphorylated in normal human immature T cells.
Gouy H; Debré P; Bismuth G
Eur J Immunol; 1995 Nov; 25(11):3030-4. PubMed ID: 7489739
[TBL] [Abstract][Full Text] [Related]
11. Tyrosine phosphorylation of p95Vav in myeloid cells is regulated by GM-CSF, IL-3 and steel factor and is constitutively increased by p210BCR/ABL.
Matsuguchi T; Inhorn RC; Carlesso N; Xu G; Druker B; Griffin JD
EMBO J; 1995 Jan; 14(2):257-65. PubMed ID: 7530656
[TBL] [Abstract][Full Text] [Related]
12. Interferon alpha induces rapid tyrosine phosphorylation of the vav proto-oncogene product in hematopoietic cells.
Platanias LC; Sweet ME
J Biol Chem; 1994 Feb; 269(5):3143-6. PubMed ID: 7508909
[TBL] [Abstract][Full Text] [Related]
13. Tyrosine phosphorylation of the vav proto-oncogene product in activated B cells.
Bustelo XR; Barbacid M
Science; 1992 May; 256(5060):1196-9. PubMed ID: 1375396
[TBL] [Abstract][Full Text] [Related]
14. A functional T-cell receptor signaling pathway is required for p95vav activity.
Wu J; Katzav S; Weiss A
Mol Cell Biol; 1995 Aug; 15(8):4337-46. PubMed ID: 7623828
[TBL] [Abstract][Full Text] [Related]
15. Insulin-dependent tyrosine phosphorylation of the vav protooncogene product in cells of hematopoietic origin.
Uddin S; Katzav S; White MF; Platanias LC
J Biol Chem; 1995 Mar; 270(13):7712-6. PubMed ID: 7535775
[TBL] [Abstract][Full Text] [Related]
16. The protein tyrosine kinase ZAP-70 can associate with the SH2 domain of proto-Vav.
Katzav S; Sutherland M; Packham G; Yi T; Weiss A
J Biol Chem; 1994 Dec; 269(51):32579-85. PubMed ID: 7798261
[TBL] [Abstract][Full Text] [Related]
17. The SH2 and SH3 domain-containing Nck protein is oncogenic and a common target for phosphorylation by different surface receptors.
Li W; Hu P; Skolnik EY; Ullrich A; Schlessinger J
Mol Cell Biol; 1992 Dec; 12(12):5824-33. PubMed ID: 1333047
[TBL] [Abstract][Full Text] [Related]
18. Vav family proteins couple to diverse cell surface receptors.
Moores SL; Selfors LM; Fredericks J; Breit T; Fujikawa K; Alt FW; Brugge JS; Swat W
Mol Cell Biol; 2000 Sep; 20(17):6364-73. PubMed ID: 10938113
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-2 induces tyrosine phosphorylation of the vav proto-oncogene product in human T cells: lack of requirement for the tyrosine kinase lck.
Evans GA; Howard OM; Erwin R; Farrar WL
Biochem J; 1993 Sep; 294 ( Pt 2)(Pt 2):339-42. PubMed ID: 7690544
[TBL] [Abstract][Full Text] [Related]
20. Analysis of receptor signaling pathways by mass spectrometry: identification of vav-2 as a substrate of the epidermal and platelet-derived growth factor receptors.
Pandey A; Podtelejnikov AV; Blagoev B; Bustelo XR; Mann M; Lodish HF
Proc Natl Acad Sci U S A; 2000 Jan; 97(1):179-84. PubMed ID: 10618391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
